Your browser doesn't support javascript.
loading
Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer.
Nyrop, K A; Damone, E M; Deal, A M; Wheeler, S B; Charlot, M; Reeve, B B; Basch, E; Shachar, S S; Carey, L A; Reeder-Hayes, K E; Dees, E C; Jolly, T A; Kimmick, G G; Karuturi, M S; Reinbolt, R E; Speca, J C; Wood, W A; Muss, H B.
Affiliation
  • Nyrop KA; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA. kirsten_nyrop@med.unc.edu.
  • Damone EM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. kirsten_nyrop@med.unc.edu.
  • Deal AM; Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Wheeler SB; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Charlot M; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Reeve BB; Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Basch E; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.
  • Shachar SS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Carey LA; Duke University School of Medicine, Durham, NC, USA.
  • Reeder-Hayes KE; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.
  • Dees EC; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Jolly TA; Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Kimmick GG; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Karuturi MS; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.
  • Reinbolt RE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Speca JC; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.
  • Wood WA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Muss HB; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.
Breast Cancer Res Treat ; 191(2): 409-422, 2022 Jan.
Article in En | MEDLINE | ID: mdl-34739658
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Aspects: Patient_preference Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Aspects: Patient_preference Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2022 Document type: Article Affiliation country: Country of publication: